Higher cannabis use in HIV and respiratory disease patients raises treatment concerns

This comprehensive study examined cannabis use patterns and cannabis use disorder (CUD) among 47,100 US adults with chronic medical conditions using 2022 national survey data. The research revealed striking differences across disease types: while cannabis use was generally lower in those with cardiovascular disease and kidney/liver conditions, adults with respiratory diseases showed higher cannabis use (26.76% past-year) and those with HIV/AIDS had dramatically elevated rates (51.58% past-year). These findings challenge assumptions about cannabis use being uncommon in medically vulnerable populations.

The study identified important risk factors beyond cannabis itself that correlate with CUD development among people with chronic illnesses. Past-year illicit drug use, nicotine dependence, and major depressive episodes were consistently linked to higher CUD prevalence. Younger adults aged 18-25 were particularly vulnerable to developing CUD, while those 35 and older showed lower rates. Notably, CUD prevalence was lower overall among those with medical conditions (5.78%) except for respiratory disease patients (9.10%), suggesting that chronic illness alone doesn't universally increase disorder risk, but certain health conditions and co-occurring mental health issues do compound vulnerability.

These findings have significant clinical implications, highlighting the urgent need for healthcare providers to screen cannabis users with chronic medical conditions and offer evidence-based treatment. The research underscores that cannabis use among medically vulnerable populations isn't uniform—disease type, age, mental health status, and other substance use patterns all play critical roles in determining who develops problematic cannabis use patterns requiring intervention.